BACKGROUND AND OBJECTIVE: Oral mucositis (OM) is a common and severe complication of many cancer therapies. Currently, prediction and early detection are not possible and objective monitoring remains problematic. Goal of this prospective study is to assess non-invasive imaging using optical coherence tomography (OCT) for early detection and evaluation of chemotherapy-induced OM in 48 patients, 12 of whom developed clinical mucositis. STUDY DESIGN/ MATERIALS AND METHODS: In 48 patients receiving neoadjuvant chemotherapy for primary breast cancer, oral mucosal health was assessed clinically, and imaged using non-invasive OCT. Images were evaluated for mucositis using an imaging-based scoring system ranging from 0 to 6. Conventional clinical assessment using the OM assessment scale (OMAS) was used as the gold standard. Patients were evaluated on Days 0-11 after commencement of chemotherapy. OCT images were visually scored by three blinded investigators. RESULTS: The following events were identified from OCT images (1) change in epithelial thickness and subepithelial tissue integrity (beginning on Day 2), (2) loss of surface keratinized layer continuity (beginning on Day 4), (3) loss of epithelial integrity (beginning on Day 4). Imaging data gave higher scores compared to clinical scores early in treatment, suggesting that the imaging-based diagnostic scoring was more sensitive to early mucositic change than the clinical scoring system. Once mucositis was established, imaging and clinical scores converged. CONCLUSION: Using OCT imaging and a novel scoring system, earlier, more sensitive detection of mucositis was possible than using OMAS. Specific imaging-based changes were a consistent predictor of clinical mucositis.
BACKGROUND AND OBJECTIVE:Oral mucositis (OM) is a common and severe complication of many cancer therapies. Currently, prediction and early detection are not possible and objective monitoring remains problematic. Goal of this prospective study is to assess non-invasive imaging using optical coherence tomography (OCT) for early detection and evaluation of chemotherapy-induced OM in 48 patients, 12 of whom developed clinical mucositis. STUDY DESIGN/ MATERIALS AND METHODS: In 48 patients receiving neoadjuvant chemotherapy for primary breast cancer, oral mucosal health was assessed clinically, and imaged using non-invasive OCT. Images were evaluated for mucositis using an imaging-based scoring system ranging from 0 to 6. Conventional clinical assessment using the OM assessment scale (OMAS) was used as the gold standard. Patients were evaluated on Days 0-11 after commencement of chemotherapy. OCT images were visually scored by three blinded investigators. RESULTS: The following events were identified from OCT images (1) change in epithelial thickness and subepithelial tissue integrity (beginning on Day 2), (2) loss of surface keratinized layer continuity (beginning on Day 4), (3) loss of epithelial integrity (beginning on Day 4). Imaging data gave higher scores compared to clinical scores early in treatment, suggesting that the imaging-based diagnostic scoring was more sensitive to early mucositic change than the clinical scoring system. Once mucositis was established, imaging and clinical scores converged. CONCLUSION: Using OCT imaging and a novel scoring system, earlier, more sensitive detection of mucositis was possible than using OMAS. Specific imaging-based changes were a consistent predictor of clinical mucositis.
Authors: Kostadinka Bizheva; Angelika Unterhuber; Boris Hermann; Boris Povazay; Harald Sattmann; A F Fercher; Wolfgang Drexler; Matthias Preusser; Herbert Budka; Andreas Stingl; Tuan Le Journal: J Biomed Opt Date: 2005 Jan-Feb Impact factor: 3.170
Authors: Bijal J Modi; Brian Knab; Lawrence E Feldman; Arno J Mundt; Mike Yao; Kristen B Pytynia; Joel Epstein Journal: Expert Opin Pharmacother Date: 2005-06 Impact factor: 3.889
Authors: Thierry M Muanza; Ana P Cotrim; Mathew McAuliffe; Anastasia L Sowers; Bruce J Baum; John A Cook; Felix Feldchtein; Paul Amazeen; C Norman Coleman; James B Mitchell Journal: Clin Cancer Res Date: 2005-07-15 Impact factor: 12.531
Authors: Petra Wilder-Smith; Marie J Hammer-Wilson; Jun Zhang; Qiang Wang; Kathryn Osann; Zhongping Chen; Harvey Wigdor; Joel Schwartz; Joel Epstein Journal: Clin Cancer Res Date: 2007-04-15 Impact factor: 12.531
Authors: S T Sonis; G Oster; H Fuchs; L Bellm; W Z Bradford; J Edelsberg; V Hayden; J Eilers; J B Epstein; F G LeVeque; C Miller; D E Peterson; M M Schubert; F K Spijkervet; M Horowitz Journal: J Clin Oncol Date: 2001-04-15 Impact factor: 44.544
Authors: James M Ridgway; William B Armstrong; Shuguang Guo; Usama Mahmood; Jianping Su; Ryan P Jackson; Terry Shibuya; Roger L Crumley; Mai Gu; Zhongping Chen; Brian J-F Wong Journal: Arch Otolaryngol Head Neck Surg Date: 2006-10
Authors: Charlotte Theresa Trebing; Sinan Sen; Stefan Rues; Christopher Herpel; Maria Schöllhorn; Christopher J Lux; Peter Rammelsberg; Franz Sebastian Schwindling Journal: Heliyon Date: 2021-04-08